Skip to content

144Accepted Dec 5, 8:54 AM ET

EyePoint Pharmaceuticals, Inc. 144

Ocumension Therapeutics

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

8:54 AM

Dec 5, 2023

Filed

Dec 5, 2023

Documents

1

Size

4.9 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.